PainReform (PRFX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PainReform Ltd. has appointed Eyal Broder as the Interim Chief Financial Officer, succeeding Dr. Ehud Geller, who remains the Executive Chairman and Interim CEO. The company regained compliance with Nasdaq’s minimum bid price requirement after a period of non-compliance. These changes could influence investor confidence as PainReform navigates its financial and operational strategies.
For further insights into PRFX stock, check out TipRanks’ Stock Analysis page.